QL Biopharm
PrivateLast Round
Series C
Mar 2, 2026
Est. Valuation
$417.5M
Total Funding Raised
$158.5M
Company Overview
QL Biopharm is a biotechnology company that develops innovative drugs for chronic metabolic diseases such as obesity, diabetes, and non-alcoholic fatty liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QL Biopharm Comparables
Compare QL Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sciwind Biosciences | 85% | |
| PegBio Co Ltd | 81% | |
| Gmax Biopharm | 80% | |
QL Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 2, 2026 | ||||
| Series C | Feb 17, 2025 | ||||
| Series B Extension | Nov 27, 2023 | ||||
| Series B | Mar 6, 2023 | ||||
| Series B | Feb 15, 2022 | ||||
Series A | Oct 27, 2020 |
QL Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Series B Extension, Series B |
| BioTrack Capital | Series A |
| TF Capital | Series C |
| Jiyuan Capital | Series B Extension |
| Tigeryeah Capital | Series C, Series A |
| OrbiMed | Series C |
| 中国风险投资有限公司 | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2023
$28M round led by China-US Green Fund and Imeik Technology.
QL Biopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QL Biopharm's valuation, stock price, and market status.